Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus

Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenz...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2017-03, Vol.215 (6), p.847-855
Main Authors: Martínez-Baz, Iván, Casado, Itziar, Navascués, Ana, Díaz-González, Jorge, Aguinaga, Aitziber, Barrado, Laura, Delfrade, Josu, Ezpeleta, Carmen, Castilla, Jesús
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Case-Control Studies
Child
Child, Preschool
Female
Humans
Influenza A Virus, H1N1 Subtype
Influenza Vaccines - administration & dosage
Influenza Vaccines - therapeutic use
Influenza, Human - epidemiology
Influenza, Human - prevention & control
Logistic Models
Male
Middle Aged
Spain
Vaccination
VIRUSES
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. The 2009 pandemic influenza A(H1N1) (A[H1N1]pdm09) vaccine component has remained unchanged from 2009. We estimate the effectiveness of current and prior inactivated influenza (AH1N1)pdm09 vaccination from influenza seasons 2010–2011 to 2015–2016. Methods. Patients attended with influenza-like illness were tested for influenza. Four periods with continued A(H1N1)pdm09 circulation were included in a test-negative design. Results. We enrolled 1278 cases and 2343 controls. As compared to individuals never vaccinated against influenza A(H1N1) pdm09, the highest effectiveness (66%; 95% confidence interval, 49%–78%) was observed in those vaccinated in the current season who had received 1–2 prior doses. The effectiveness was not statistically lower in individuals vaccinated in the current season only (52%) or in those without current vaccination and >2 prior doses (47%). However, the protection was lower in individuals vaccinated in the current season after >2 prior doses (38%; P = .009) or those currently unvaccinated with 1–2 prior doses (10%; P < .001). Current-season vaccination improved the effect in individuals with 1–2 prior doses and did not modify significantly the risk of influenza in individuals with >2 prior doses. Conclusion. Current vaccination or several prior doses were needed for high protection. Despite the decreasing effect of repeated vaccination, current-season vaccination was not inferior to no current-season vaccination.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jix055